Status:
UNKNOWN
Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad)
Lead Sponsor:
Azienda Policlinico Umberto I
Collaborating Sponsors:
University of Bari Aldo Moro
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
The investigators provided a multicenter analysis aiming to investigate, in a clinical practice setting, the prognostic relevance of previous primary radical prostatectomy (RP) or external beam radiot...
Eligibility Criteria
Inclusion
- histological confirmation of prostatic adenocarcinoma, at least two symptomatic bone secondary lesions detected by bone scan and no known visceral metastases, except for malignant lymphadenopathy with less than 3 cm in the short axis diameter
Exclusion
- Eastern Cooperative Oncology Group (ECOG) performance status (PS) score \>2 and inadequate hematological, hepatic and renal function
Key Trial Info
Start Date :
September 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04110782
Start Date
September 1 2015
End Date
January 1 2020
Last Update
October 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico Umberto I
Rome, Italy, 00161